HomeINNPF • OTCMKTS
add
Innocan Pharma Corp
Previous close
$0.21
Day range
$0.20 - $0.20
Year range
$0.14 - $0.35
Market cap
74.58M CAD
Avg Volume
775.00
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 4.89M | 331.10% |
Operating expense | 5.18M | 106.49% |
Net income | -883.00K | 26.84% |
Net profit margin | -18.05 | 83.03% |
Earnings per share | — | — |
EBITDA | -886.00K | 36.53% |
Effective tax rate | -36.77% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.88M | -21.47% |
Total assets | 6.94M | -0.52% |
Total liabilities | 2.55M | 240.08% |
Total equity | 4.39M | — |
Shares outstanding | 280.66M | — |
Price to book | 10.40 | — |
Return on assets | -32.38% | — |
Return on capital | -50.03% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -883.00K | 26.84% |
Cash from operations | -1.31M | 3.89% |
Cash from investing | -9.00K | 43.75% |
Cash from financing | 1.12M | 56,000.00% |
Net change in cash | -139.00K | 90.54% |
Free cash flow | -501.75K | 57.58% |
About
Founded
2018
Website
Employees
8